Stone Bond Technologies EE-LIMS Earns GeneChip-compatible™ Status with the Affymetrix GeneChip® Microarray Platform
News Apr 05, 2006
Stone Bond Technologies has announced that its Enterprise Enabler® and EE-LIMS systems have achieved GeneChip-compatible™ status with the Affymetrix Inc. GeneChip® microarray platform for gene expression and genetic variation analysis in biomedical research and development.
As a GeneChip-compatible software provider and participant in the Affymetrix GeneChip-compatible Applications Program, Stone Bond’s Enterprise Enabler integrates seamlessly with the Affymetrix GeneChip microarray platform.
As a result, laboratories can automate sample data import and test result outflow to and from the Affymetrix GeneChip Operating Software (GCOS) using Stone Bond’s EE-LIMS system, saving time, reducing errors and lowering lab administrative costs.
“Today’s lab manager is under increasing pressure to reduce administrative costs and improve efficiencies and lab economics,” noted Stone Bond President and Chief Executive Officer Antonio Szabo.
“As genetic research becomes more complex, technology that delivers automation compatibility to leverage existing capital investments in the lab provides additive value to streamline operations and help manage research overhead costs.
"We are honored that Affymetrix, the world leader in genetic research technology, has recognized Stone Bond’s EE-LIMS system as a compatible solution to work in partnership with their GeneChip platform.”
“As Affymetrix customers continue to scale up and industrialize their GeneChip microarray experiments for biomedical research, LIMS systems will become more and more important,” said Steve Lincoln, vice president of Informatics at Affymetrix.
“We are pleased to be working with Stone Bond to provide critical data handling and processing in an automated manner.”
In a new study in cells, University of Illinois researchers have adapted CRISPR gene-editing technology to cause the cell’s internal machinery to skip over a small portion of a gene when transcribing it into a template for protein building. This gives researchers a way not only to eliminate a mutated gene sequence, but to influence how the gene is expressed and regulated.
Researchers published today a detailed description of the complete genome of bread wheat, the world's most widely-cultivated crop. This work will pave the way for the production of wheat varieties better adapted to climate challenges, with higher yields, enhanced nutritional quality and improved sustainability.